# WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?

> **NCT04990791** · PHASE4 · COMPLETED · sponsor: **Sheffield Teaching Hospitals NHS Foundation Trust** · enrollment: 48 (actual)

## Conditions studied

- Coronary Syndrome

## Interventions

- **DRUG:** Aspirin 75mg
- **DRUG:** Aspirin 20mg
- **DRUG:** Rivaroxaban 2.5 mg

## Key facts

- **NCT ID:** NCT04990791
- **Lead sponsor:** Sheffield Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-26
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-12-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04990791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04990791, "WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT04990791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*